CNS organoids: an innovative tool for neurological disease modeling and drug neurotoxicity screening.


Journal

Drug discovery today
ISSN: 1878-5832
Titre abrégé: Drug Discov Today
Pays: England
ID NLM: 9604391

Informations de publication

Date de publication:
02 2020
Historique:
received: 23 08 2019
revised: 28 10 2019
accepted: 20 11 2019
pubmed: 30 11 2019
medline: 1 5 2021
entrez: 30 11 2019
Statut: ppublish

Résumé

The paradigm of central nervous system (CNS) drug discovery has mostly relied on traditional approaches of rodent models or cell-based in vitro models. Owing to the issues of species differences between humans and rodents, it is difficult to correlate the robustness of data for neurodevelopmental studies. With advances in the stem-cell field, 3D CNS organoids have been developed and explored owing to their resemblance to the human brain architecture and functions. Further, CNS organoids provide a unique opportunity to mimic the human brain physiology and serve as a modeling tool to study the normal versus pathological brain or the elucidation of mechanisms of neurological disorders. Here, we discuss the recent application of a CNS organoid explored for neurodevelopment disease or a screening tool for CNS drug development.

Identifiants

pubmed: 31783130
pii: S1359-6446(19)30452-0
doi: 10.1016/j.drudis.2019.11.010
pmc: PMC7039749
mid: NIHMS1547143
pii:
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

456-465

Subventions

Organisme : NIDA NIH HHS
ID : R03 DA044877
Pays : United States

Informations de copyright

Copyright © 2019 Elsevier Ltd. All rights reserved.

Références

Ann N Y Acad Sci. 2000;909:217-32
pubmed: 10911932
J Neurosci. 2017 Oct 11;37(41):9917-9924
pubmed: 28912154
Nat Protoc. 2016 Sep;11(9):1724-43
pubmed: 27560176
Nat Med. 2016 Nov;22(11):1220-1228
pubmed: 27783065
Neuron. 2017 Aug 16;95(4):779-790.e6
pubmed: 28817799
Nat Commun. 2019 Jun 13;10(1):2612
pubmed: 31197141
Nat Biotechnol. 2017 Jul;35(7):659-666
pubmed: 28562594
Nat Commun. 2018 Oct 9;9(1):4167
pubmed: 30301888
Cell Rep. 2015 Feb 3;10(4):537-50
pubmed: 25640179
Transl Psychiatry. 2017 Nov 17;7(11):6
pubmed: 30446636
Nat Biotechnol. 2018 Jun;36(5):432-441
pubmed: 29658944
Cell Stem Cell. 2019 Jun 6;24(6):908-926.e8
pubmed: 31130512
PLoS One. 2018 Dec 17;13(12):e0209150
pubmed: 30557391
Science. 2016 May 13;352(6287):816-8
pubmed: 27064148
Lab Chip. 2015 Jan 7;15(1):141-50
pubmed: 25317977
N Engl J Med. 2016 Mar 10;374(10):951-8
pubmed: 26862926
Stem Cells Transl Med. 2017 Feb;6(2):622-633
pubmed: 28191779
Development. 2017 Mar 15;144(6):1118-1127
pubmed: 28174241
Nat Methods. 2015 Jul;12(7):671-8
pubmed: 26005811
Dev Biol. 2016 Dec 15;420(2):199-209
pubmed: 27402594
Cell Stem Cell. 2012 Jun 14;10(6):771-785
pubmed: 22704518
Neuropsychopharmacology. 2017 Feb;42(3):774-784
pubmed: 27534267
Stem Cell Reports. 2016 Apr 12;6(4):525-538
pubmed: 27050948
Nature. 2009 May 14;459(7244):262-5
pubmed: 19329995
Bioengineering (Basel). 2019 Jan 18;6(1):
pubmed: 30669275
Br J Pharmacol. 2011 Oct;164(4):1162-94
pubmed: 21449915
Cell. 2016 Jun 16;165(7):1586-1597
pubmed: 27315476
Nat Protoc. 2014 Oct;9(10):2329-40
pubmed: 25188634
ACS Chem Neurosci. 2018 Feb 21;9(2):167-176
pubmed: 29185709
Nature. 2010 Nov 11;468(7321):203-12
pubmed: 21068828
Mol Psychiatry. 2018 Dec;23(12):2363-2374
pubmed: 30171212
Nat Commun. 2015 Nov 17;6:8896
pubmed: 26573335
Front Synaptic Neurosci. 2018 Jun 08;10:15
pubmed: 29937727
Nat Neurosci. 2019 Apr;22(4):669-679
pubmed: 30886407
Dev Dyn. 2019 Jan;248(1):53-64
pubmed: 30091290
Nat Methods. 2019 Nov;16(11):1169-1175
pubmed: 31591580
Cell. 2019 Feb 7;176(4):743-756.e17
pubmed: 30735633
Sci Rep. 2018 May 9;8(1):7413
pubmed: 29743549
SLAS Discov. 2018 Sep;23(8):862-868
pubmed: 29543559
Development. 2017 Mar 15;144(6):968-975
pubmed: 28292843
Nature. 2013 Sep 19;501(7467):373-9
pubmed: 23995685
Nat Neurosci. 2018 Jul;21(7):941-951
pubmed: 29950669
ALTEX. 2017;34(3):362-376
pubmed: 27883356
Cell Rep. 2019 Mar 19;26(12):3203-3211.e5
pubmed: 30893594
Neuron. 2017 Dec 6;96(5):1041-1054.e5
pubmed: 29103808
ALTEX. 2014;31(2):129-56
pubmed: 24687333
Nat Methods. 2018 Aug;15(8):631-639
pubmed: 30038414
Cell. 2015 Jul 16;162(2):375-390
pubmed: 26186191
Cell Stem Cell. 2019 Oct 3;25(4):462-472
pubmed: 31585092
J Med Ethics. 2018 Sep;44(9):606-610
pubmed: 29491041
Cell Stem Cell. 2017 Mar 2;20(3):397-406.e5
pubmed: 28132835
Cell Rep. 2017 Apr 4;19(1):50-59
pubmed: 28380362
Development. 2019 Apr 16;146(8):
pubmed: 30992274
Eur J Pharmacol. 2016 Nov 5;790:12-20
pubmed: 27375081
Neuroscience. 2019 Apr 15;404:530-540
pubmed: 30599272
Cell Stem Cell. 2016 Aug 4;19(2):258-265
pubmed: 27162029
Cell Rep. 2018 Apr 24;23(4):1220-1229
pubmed: 29694897
Cell Stem Cell. 2016 Jan 7;18(1):25-38
pubmed: 26748754
Immunity. 2017 Mar 21;46(3):446-456
pubmed: 28314593
Integr Biol (Camb). 2017 Dec 11;9(12):968-978
pubmed: 29168871
Am J Physiol Lung Cell Mol Physiol. 2016 May 15;310(10):L889-98
pubmed: 26968771
J Neuropsychiatry Clin Neurosci. 2013 Winter;25(1):26-31
pubmed: 23487190
J Biosens Bioelectron. 2016 Mar;7(1):
pubmed: 27280058
Ther Drug Monit. 2010 Apr;32(2):206-15
pubmed: 20216119
Cell. 2016 May 19;165(5):1238-1254
pubmed: 27118425
Cell Death Dis. 2019 Apr 11;10(4):325
pubmed: 30975982
Eur Rev Med Pharmacol Sci. 2013 Aug;17(16):2198-206
pubmed: 23893187
Nature. 2017 May 4;545(7652):54-59
pubmed: 28445465
Neuron. 2018 Oct 24;100(2):389-405
pubmed: 30359604
Science. 2014 Jul 18;345(6194):1247125
pubmed: 25035496
Nature. 2017 May 4;545(7652):48-53
pubmed: 28445462
Toxicol Appl Pharmacol. 2018 Sep 1;354:101-114
pubmed: 29428530
Lab Chip. 2018 Mar 13;18(6):851-860
pubmed: 29437173
Nat Med. 2016 Oct;22(10):1101-1107
pubmed: 27571349
PLoS One. 2016 Sep 13;11(9):e0161969
pubmed: 27622770
Nature. 2016 May 11;534(7606):267-71
pubmed: 27279226
Cell Stem Cell. 2017 Apr 6;20(4):435-449.e4
pubmed: 28111201
Nat Med. 2019 Apr;25(4):561-568
pubmed: 30858616
J Pharmacol Exp Ther. 2019 Jul;370(1):9-17
pubmed: 31028107
Nature. 2011 May 12;473(7346):221-5
pubmed: 21490598
Sci Rep. 2017 Mar 27;7:45091
pubmed: 28345587
Nat Med. 2011 Nov 27;17(12):1657-62
pubmed: 22120178
Bioengineering (Basel). 2019 Apr 30;6(2):
pubmed: 31052208
Stem Cell Res. 2019 Jul;38:101441
pubmed: 31082678
Mol Psychiatry. 2018 Apr;23(4):1051-1065
pubmed: 28439102

Auteurs

Tanya Chhibber (T)

Department of Pharmaceutical Sciences, JH School of Pharmacy, Texas Tech University Health Sciences Center (TTUHSC), Amarillo, TX 79106, USA.

Sounak Bagchi (S)

Department of Pharmaceutical Sciences, JH School of Pharmacy, Texas Tech University Health Sciences Center (TTUHSC), Amarillo, TX 79106, USA.

Behnaz Lahooti (B)

Department of Pharmaceutical Sciences, JH School of Pharmacy, Texas Tech University Health Sciences Center (TTUHSC), Amarillo, TX 79106, USA.

Angela Verma (A)

Department of Pharmaceutical Sciences, JH School of Pharmacy, Texas Tech University Health Sciences Center (TTUHSC), Amarillo, TX 79106, USA.

Abraham Al-Ahmad (A)

Department of Pharmaceutical Sciences, JH School of Pharmacy, Texas Tech University Health Sciences Center (TTUHSC), Amarillo, TX 79106, USA.

Manash K Paul (MK)

Division of Pulmonary and Critical Care Medicine, David Geffen School of Medicine, University of California Los Angeles (UCLA), Los Angeles, CA 90095, USA.

Gurudutt Pendyala (G)

Department of Anesthesiology, College of Medicine, University of Nebraska Medical Center (UNMC), Omaha, NE 68198, USA.

Rahul Dev Jayant (RD)

Department of Pharmaceutical Sciences, JH School of Pharmacy, Texas Tech University Health Sciences Center (TTUHSC), Amarillo, TX 79106, USA. Electronic address: rd.jayant@ttuhsc.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH